Inpatient Rsv-Management 2016–2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children’s Hospital
Klinische Pädiatrie · 01.07.2025 · 237 (04) · 243-249
DOI: 10.1055/a-2218-5171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.07.2025. Verfasst von Solvej Heidtmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Oncology and Hematology, TeleKasper Project, Saarland University Hospital, Homburg, Germany. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Guideline Adherence, Hospitals, Pediatric, Bronchiolitis, Viral. Die Arbeit nennt 35 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
This study analyzes the RSV season 2021/2022 in a referral children’s hospital, compares the epidemiology and illness severity with RSV-infected inpatients from 2016 to 2020 and audits the adherence to our internal therapy standard for RSV bronchiolitis. Material and methods Inpatients with rtPCR-confirmed RSV infection (Jan. 2016 to Jan. 2022).
Results
The audit comprises 306 RSV inpatients, on average 50 hospitalizations per year; in 03/2020, a rapid RSV Season-Offset was observed. In the winter season 2020/2021, no patient with RSV was hospitalized. Beginning in July, we noticed a rapid increase of RSV-admissions (most cases in Sept./Oct, duration until Dec. 2021; n=53). In 2021–2022, a significant larger share needed PICU admission (9.4% vs 3.2%, p=0.040). Adherence to the internal guidance was low; only 11.8% (n=36) of all patients received supportive treatment without inhalative or systemic medications, 37% of all patients received antibiotics.
Conclusions
This audit confirms the strong impact of public preventive measures directed against SARS-CoV-2 transmission on RSV epidemiology. Few weeks after easing public COVID-19 restrictions (summer 2021), RSV inpatient cases rapidly increased, lasting until Dec. 2021. The audit of bronchiolitis management revealed surprisingly low adherence to the internal guidance, despite a face-to-face educational session with the attending pediatricians in Oct. 2021. Low adherence resulted in an unnecessary exposure of RSV patients to systemic medications of questionable benefit including antibiotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Pediatric Oncology and Hematology, TeleKasper Project, Saarland University Hospital, Homburg, Germany.
- General Pediatrics and Neonatology, University Children̓s Hospital Homburg, Homburg, Germany.
- Pediatric Haematology and Oncology, Saarland University Hospital, Homburg/Saar, Germany.
- Institute of Virology, Saarland University Medical Center, Homburg/Saar, Germany.
- Pediatric Oncology and Hematology, Saarland University Hospital, Homburg, Germany.
ORCID-Profile: Michael Zemlin
Zitieren
APA
Heidtmann, S., Baltaci, Y., Meyer, S., Zemlin, M., Furtwängler, R., Rissland, J., & Simon, A. (2025). Inpatient Rsv-Management 2016–2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children’s Hospital. Klinische Pädiatrie, 237(04), 243-249. https://doi.org/10.1055/a-2218-5171
Vancouver
Heidtmann S, Baltaci Y, Meyer S, Zemlin M, Furtwängler R, Rissland J, et al. Inpatient Rsv-Management 2016–2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children’s Hospital. Klinische Pädiatrie. 2025;237(04):243-249. doi:10.1055/a-2218-5171
BibTeX
@article{Heidtmann2025,
author = {Heidtmann, Solvej and Baltaci, Yeliz and Meyer, Sascha and Zemlin, Michael and Furtwängler, Rhoikos and Rissland, Juergen and Simon, Arne},
title = {Inpatient Rsv-Management 2016–2022: Epidemiology and Adherence to A Bronchiolitis Treatment Standard at a German University Children’s Hospital},
journal = {Klinische Pädiatrie},
year = {2025},
volume = {237},
number = {04},
pages = {243--249},
doi = {10.1055/a-2218-5171}
}
EUVIMED